OTSUKA CORP./ JP3188200004 /
| 2024-05-03 8:05:43 AM | Chg. +0.2000 | Volume | Bid4:13:34 PM | Ask4:01:07 PM | High | Low |
|---|---|---|---|---|---|---|
| 17.5000EUR | +1.16% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 17.5000 | 17.5000 |
GlobeNewswire
04-30
EU Nephrologists Foresee Travere/CSL Vifor’s FILSPARITM (sparsentan) Transforming IgA Nephropathy Tr...
GlobeNewswire
04-18
Recor Medical Announces First Cases of Paradise Ultrasound Renal Denervation Therapy in the United A...
Newsfile Corp
04-12
131 and Syntheia Announce Signing of Amended and Restated Definitive Agreement and Private Placement...
GlobeNewswire
04-03
Astex Pharmaceuticals Announce Key Data Presentations at the American Association For Cancer Researc...
GlobeNewswire
03-15
American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...
GlobeNewswire
03-14
IgA Nephropathy Pipeline Dynamics Signal Further Treatment Evolution on the Horizon
GlobeNewswire
02-29
Kidney Month: 31 Day of Action to Equip and Empower People to Fight Kidney Disease
GlobeNewswire
02-22
OncoC4 Announces First Patient with Advanced Prostate Cancer Dosed in Phase 1/2 Trial of BioNTech-pa...
GlobeNewswire
2023-12-05
American Kidney Fund Hosts Fourth National Summit on Unknown Causes of Kidney Disease
GlobeNewswire
2023-11-20
Third Success from Astex Drug Discovery Pharma Collaboration and Licence Agreements as AstraZeneca R...
GlobeNewswire
2023-11-14
IBN Announces Latest Episode of The Bell2Bell Podcast featuring Wa’el Hashad, CEO of Longeveron Inc.
Newsfile Corp
2023-10-19
Pioneers and Innovators in Psilocybin Treatments and How Big Pharma Wants in on the Game
GlobeNewswire
2023-10-13
US Nephrologists Embrace Current IgA Nephropathy Therapies, Yet a Thriving Pipeline Signals Fierce M...
GlobeNewswire
2023-09-07
Otsuka collaborates with ShapeTX to develop novel AAV gene therapies for ocular diseases
